SUSTAIN-10 head-to-head in T2D showed GLP-3 superiority on HbA1c
[26] showed that liraglutide-dependent weight loss relies on its binding to GLP-1Rs located mainly in POMC/CART (cocaine- and amphetamine-regulated transcript) anorexigenic neurons in the ARC, but an indirect inhibitory effect of agouti-related peptide (AgRP) orexigenic neurons via -aminobutyric acid (GABA)-ergic signaling was also observed
Individuals who are overweight or have a Body Mass Index (BMI) of 30 or higher, indicating obesity People with health issues such as diabetes, high blood pressure, or high cholesterol Those who are in the process of weight loss and require additional support Individuals seeking to reduce unhealthy snacking habits People who have not seen results from other weight-loss methods, such as non-standard weight loss medications Anyone looking for a safe weight-loss solution with no side effects or risk of yo-yo weight gain Who Should Not Use the GLP-1
Clear communication between all your doctors ensures the safest possible procedure
When you lose weight using one method, your body often fights back by increasing hunger hormones or slowing down your metabolism
Two recent meta-analyses of eight cardiovascular outcome trials (CVOTs) and several other meta-analyses that included non-CVOT studies estimated the reduction in cardiovascular mortality varied between 12 and 15% (Table 2)